Thor Medical Share Price Nasdaq Stockholm
Stocks
NANOVO
NO0010597883
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq Stockholm
17:00:00 22/09/2026 BST
|
After hours 15:20:00 | |||
| 4.700 NOK | -0.32% |
|
4.593 | -2.28% |
| 08-28 | Thor Medical ASA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 08-28 | Thor Medical ASA, H1 2026 Earnings Call, Aug 28, 2026 |
| Market Cap | 1.95B 205M 181M 170M 155M 290M 19.71B 293M 2.04B 792M 10.03B 771M 754M 32.64B | P/E 2026 * |
-23.1x | P/E 2027 * | -38.5x |
|---|---|---|---|---|---|
| Enterprise Value | 2.15B 226M 199M 187M 171M 320M 21.69B 322M 2.25B 871M 11.04B 848M 830M 35.93B | EV / Sales 2026 * |
108x | EV / Sales 2027 * | 14.9x |
| Free-Float |
76.15% | Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmNOK
| Markets | Quality | ||
|---|---|---|---|
Oslo Bors
| NANOV | Real-time | |
CBOE
| NANOo | Real-time | |
|
London S.E.
| 0R6Y | End-of-day quote | |
|
Nasdaq Stockholm
| NANOVO | Delayed | |
|
Deutsche Boerse AG
| 8NN | Delayed | |
|
London S.E.
| 0R6Y | Delayed | |
|
CBOE
| 0R6Y | Real-time | |
|
Börse Stuttgart
| 8NN | Delayed | |
|
Boerse Muenchen
| 8NN | Real-time | |
|
Tradegate
| 8NN | Real-time | |
|
Berne S.E.
| 8NN | End-of-day quote |
Last Transcript: Thor Medical
| Current month | -19.10% | ||
| 1 month | -16.96% | ||
| 3 months | +16.77% | ||
| 6 months | -1.05% | ||
| Current year | -8.02% |
| 1 month | 4.66 |  | 7.11 |
| 3 years | 1.05 | | 7.11 |
| 5 years | 1.05 | | 28.72 |
| 10 years | 1.05 | | 125 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jasper Kurth
CEO | Chief Executive Officer | 41 | 31/07/2024 |
| Director of Finance/CFO | 37 | 30/06/2023 | |
Sindre Hassfjell
CTO | Chief Tech/Sci/R&D Officer | - | 31/05/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 67 | 27/06/2023 | |
John Andersen
CHM | Chairman | 59 | - |
| Director/Board Member | - | 23/04/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.32% | 0.00% | +3.52% | +141.03% | 206M | |
| -3.30% | +2.97% | +54.99% | +104.15% | 74.18B | |
| -0.12% | -1.63% | +33.14% | +74.86% | 59.55B | |
| +2.71% | -1.96% | -13.79% | +371.49% | 25.84B | |
| +0.81% | +0.61% | -0.49% | -3.74% | 24.73B | |
| -1.05% | +2.58% | +24.27% | -10.32% | 20.87B | |
| -1.70% | -4.15% | +147.82% | +325.69% | 15.32B | |
| +2.15% | -0.92% | +48.93% | +165.46% | 14.06B | |
| -0.43% | -7.56% | -20.10% | +753.12% | 13.12B | |
| +0.04% | -3.97% | +20.23% | +240.01% | 11.85B | |
| Average | -0.10% | -0.80% | +29.85% | +216.17% | 28.84B | |
| Weighted average by Cap. | -0.71% | -0.22% | +35.11% | +159.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 20M 2.1M 1.85M 1.74M 1.59M 2.97M 202M 3M 20.91M 8.1M 103M 7.89M 7.72M 334M | 145M 15.23M 13.4M 12.63M 11.52M 21.55M 1.46B 21.72M 152M 58.74M 744M 57.19M 55.95M 2.42B |
| Net income | -70M -7.35M -6.47M -6.1M -5.56M -10.4M -706M -10.49M -73.17M -28.36M -359M -27.61M -27.01M -1.17B | -44M -4.62M -4.07M -3.83M -3.5M -6.54M -444M -6.59M -46M -17.82M -226M -17.36M -16.98M -735M |
| Net Debt | 197M 20.7M 18.2M 17.16M 15.66M 29.28M 1.99B 29.51M 206M 79.8M 1.01B 77.71M 76.02M 3.29B | 201M 21.12M 18.57M 17.51M 15.97M 29.87M 2.03B 30.11M 210M 81.42M 1.03B 79.28M 77.56M 3.36B |
Employees
-
| Date | Price | Change |
|---|---|---|
| 22/09/26 | NOK 4.700 | -0.32% |
| 21/09/26 | NOK 4.715 | +1.18% |
Sell
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
4.625NOK
Average target price
4.200NOK
Spread / Average Target
-9.19%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NANOV Stock
- NANOVO Stock
Select your edition
All financial news and data tailored to specific country editions
